1. Combination versus sequential chemotherapy administration: Is it time for a reevaluation of the issue?

   • Maurie Markman

   Editor’s Commentary 29 March 2008 Pages: 93 - 94

2. Web alert

   OriginalPaper 29 March 2008 Pages: 95 - 95

3. Randomized trial of bevacizumab in advanced renal cell carcinoma

   • Ronald M. Bukowski

   Clinical Trials Report 29 March 2008 Pages: 99 - 100

4. Clinical implications of caveolins in malignancy and their potential as therapeutic targets

   • Ila Tamaskar
   • Ming Zhou

   OriginalPaper 29 March 2008 Pages: 101 - 106

5. Hedgehog signaling pathway: Development of antagonists for cancer therapy

   • Jingwu Xie

   OriginalPaper 29 March 2008 Pages: 107 - 113

6. The role and target potential of protein tyrosine phosphatases in cancer

   • Taolin Yi
   • Daniel Lindner

   OriginalPaper 29 March 2008 Pages: 114 - 121

7. Tubulin-associated proteins: Aurora and Polo-like kinases as therapeutic targets in cancer

   • Steven L. Warner
   • Bret J. Stephens
   • Daniel D. Von Hoff

   OriginalPaper 29 March 2008 Pages: 122 - 129

8. Immunoregulatory T cells: Role and potential as a target in malignancy

   • Marc Beyer
   • Joachim L. Schultze

   OriginalPaper 29 March 2008 Pages: 130 - 136

9. Circulating tumor cells in solid cancer: Tumor marker of clinical relevance?

   • Loris Bertazza
   • Simone Mocellin
   • Donato Nitti

   OriginalPaper 29 March 2008 Pages: 137 - 146

10. The role of PET-CT in the management of patients with advanced cancer of the head and neck

    • June Corry
    • Danny Rischin
    • Lester J. Peters

    OriginalPaper 29 March 2008 Pages: 149 - 155

11. Paragangliomas of the head and neck

    • Michael E. Kupferman
    • Ehab Y. Hanna

    OriginalPaper 29 March 2008 Pages: 156 - 161

12. Head and neck cancer immunotherapy: Clinical evaluation

    • Michael S. Leibowitz
    • Jayakar V. Nayak
    • Robert L. Ferris

    OriginalPaper 29 March 2008 Pages: 162 - 169

13. Swing of the pendulum: Optimizing functional outcomes in larynx cancer

    • F. Christopher Holsinger

    OriginalPaper 29 March 2008 Pages: 170 - 175

14. EGFR inhibitors for the treatment of squamous cell carcinoma of the head and neck

    • Ranee Mehra
    • Roger B. Cohen
    • Paul M. Harari

    OriginalPaper 29 March 2008 Pages: 176 - 184